White Richard Allen JR 4

4 · Ingevity Corp · Filed Mar 2, 2026

AI-generated summary of this filing

Updated Mar 2, 2026

Ingevity (NGVT) SVP Richard White Receives Award and Sells Shares

What Happened

Richard Allen White Jr., Senior Vice President and President, Performance Chemicals at Ingevity (NGVT), had performance-based restricted stock units (PSUs) certified as vested and settled into 1,204 shares on Feb 26, 2026 (acquired at $0 as an award). On the same date he sold 430 shares at $70.52 each, generating proceeds of $30,324.
Net on the date: +774 shares (1,204 acquired less 430 sold). The awarded shares are compensation (not a purchase)—the sale is a disposition of existing/vested shares.

Key Details

Transaction date: February 26, 2026.
Award: 1,204 shares, acquisition price reported as $0 (PSU settlement).
Sale: 430 shares at $70.52 per share; total proceeds $30,324.
Net change: +774 shares on that date.
Footnotes:
- F1: The Talent and Compensation Committee certified performance goals and PSUs were settled in shares effective Feb 26, 2026.
- F2: The filing notes inclusion of prior Employee Stock Purchase Plan (ESPP) shares (94 shares from July–Sept 2025 and 76 shares from Oct–Dec 2025) purchased at 85% of the applicable offering-period price.
- F3: Some vested PSU shares were withheld to satisfy tax withholding obligations.
Filing timeliness: Form 4 filed March 2, 2026 — within the typical two-business-day SEC filing window for a Feb 26 transaction.

Context

These were performance-based awards settled in stock (PSUs); the $0 acquisition price reflects compensation rather than an open-market purchase. Sales following vesting are common and can reflect tax withholding or portfolio decisions; filings do not state the insider's motives.
For retail investors: acquisitions (purchases or awards retained) and sales reported by insiders are factual events — awards increase insider holdings, while sales reduce them. Here the insider ended the day with a net increase in shares (774).

Form 4

Period: 2026-02-26

SVP and Pres, Perf Chemicals

Transactions

Footnotes (3)

[F1]The Talent and Compensation Committee of the Company's board of directors certified the attainment of performance goals for certain performance-based restricted stock awards ("PSUs") effective February 26, 2026. The PSUs were settled with shares of common stock.
[F2]Includes (i) 94 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP") for the purchase period of July 1, 2025 to September 30, 2025 (the "September ESPP Shares"), and (ii) 76 shares of Common Stock purchased pursuant to the ESPP for the purchase period of October 1, 2025 to December 31, 2025 (the "December ESPP Shares"). In accordance with the terms of the ESPP, the September ESPP Shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on July 1, 2025 and the December ESPP Shares were purchased at a price equal to 85% of the closing price of the Issuer's Common Stock on October 1, 2025.
[F3]Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 26, 2026.

Signature

Richard Allen White Jr. By: Mavis Huger as Attorney-in-Fact|2026-03-02

1 file